1[1]Esty EH,Thall PF,Pierce S,et al.Randominzid phase Ⅱ study of pladarabine+cytosine aralinosidea+idarubicin± all-rians retinoic acid±granulocyte colony stimulating factor in poor prognosis newly diagnsed acute myeloid leukemia and myelodysplastic syndrome.Blood,1999,93:2478～2484.
2[2]Cottin B,Kettirlr N,Haison C,et al.A multicenter randomized phase Ⅱ study of rituximb at two dosages in patients with relapsed or refratory intermetiate srade lymphoma or in elderly Lpatients in first line therapy.Br J Haematol,1998,102:238.
3[3]Shen SH,Liang PC,Lin HC.High dose sytarabine chemotherapy with or without G-csf for child acute leukemia.Am J Hematol,1998,58:20～23.
4[4]Golwin JE,Kopecks KJ,Head DR,et al.A double blind placebo-controlled trial of G-csf in elderly patients with previously untreated acute myeloid leukemia:a southwest oncology group study.Blood,1998,91:3607～3615.
5[5]Damiani D,Micheli M,Emacora A,et al.Adjuvent treatment with cyclosprin A increase the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.Leukemia,1998,12:1236～1240.
